GleamWall
中文EN

CRBU Caribou Biosciences, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1619856 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.6%
TTM net income YoY34.8%
TTM EPS YoY39.4%
Revenue 3-yr CAGR-35.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-1,140.6%
Net margin-1,085.0%
FCF margin-984.6%
EBITDA margin-1,113.6%

Returns

ROE-93.8%
ROA-64.4%
ROIC (approx.)-93.9%
Asset turnover0.06x

Leverage & solvency

Liabilities / assets37.7%
Debt / equity0.00x
Current ratio4.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.91x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue-1.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$11.16M$9.99M
R&D expense$109.44M$130.15M
SG&A expense$37.91M$46.46M
Operating income-$148.34M-$166.62M
Pretax income-$148.68M-$149.11M
Income tax-$550,000-$9,000
Net income-$148.12M-$149.10M
EBITDA-$144.70M-$162.69M
EPS (basic)-1.59-1.65
EPS (diluted)-1.59-1.65
Weighted avg. shares (diluted)93.39M90.32M
Balance sheet
Cash & equivalents$12.36M$16.34M
Short-term investments$126.98M$193.24M
Receivables$69,000$265,000
Current assets$145.23M$219.38M
PP&E, net$6.76M$19.28M
Total assets$175.37M$313.31M
Current liabilities$25.41M$30.65M
Total liabilities$53.19M$60.36M
Shareholders' equity$122.17M$252.95M
Shares outstanding95.14M92.38M
Cash flow statement
Operating cash flow-$110.99M-$138.20M
Capital expenditure$1.36M$4.88M
Free cash flow-$112.35M-$143.08M
Investing cash flow$102.24M$86.61M
Financing cash flow$4.82M$16.72M
Depreciation & amortization$3.65M$3.93M
Stock-based compensation$12.68M$16.71M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.